Tickerplace logo

Tickerplace

Corcept Therapeutics Incorporated logo

CORTCorcept Therapeutics Incorporated

CORT Stock Price, Valuation & Chart | Corcept Therapeutics Incorporated

Compare
$110.16-3.21 (-2.83%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

CORT Historical price chart

CORT Key Stats

Market Capitalization11.91B
PE Ratio314.74
EPS0.35
Trading Volume849.63K
Today's High/Low113.64/107.79
Dividend Yield0.00
52 Week High/Low126.38/28.66
Shares Outstanding108.10M
CORT Financial Statement
CORT Analyst ratings
CORT Analysis & performance metrics

CORT Company profile

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United…

CORT Management team

Management
William Guyer Pharm.D.
Chief Development Officer
Hazel Hunt Ph.D.
Chief Scientific Officer
Joseph Douglas Lyon
Chief Accounting & Technology Officer
Joseph K. Belanoff M.D.CEO
Co-Founder, President, Chief Executive Officer & Director
Atabak MokariCFO
Chief Financial Officer & Treasurer
Amy Flood
Chief Human Resources & Communications Officer
Sean Maduck
President of Endocrinology
Roberto W. Vieira
President of Oncology
Total 8 executives

CORT Frequently asked questions

What is Corcept Therapeutics Incorporated (CORT) Stock Price?

Current stock price of Corcept Therapeutics Incorporated (CORT) stock is $110.16. The stock price is -2.83% lower in the session. The intraday range can be seen from this page. Volume of Corcept Therapeutics Incorporated (CORT) stock is 849.63K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Corcept Therapeutics Incorporated (CORT) stock price going up or down today?

The stock price of Corcept Therapeutics Incorporated (CORT) can change with earnings, company news, and overall market sentiment. Corcept Therapeutics Incorporated operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Corcept Therapeutics Incorporated stock expensive at its current price?

Whether Corcept Therapeutics Incorporated looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CORT on this page is 314.74. EPS on this page is 0.35. Compare those figures with peers and growth expectations before deciding if the current Corcept Therapeutics Incorporated price is justified.

How has the stock price of Corcept Therapeutics Incorporated (CORT) performed historically?

Historical performance for Corcept Therapeutics Incorporated (CORT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CORT reacted to past earnings and market events.

Should I buy Corcept Therapeutics Incorporated (CORT) stock, at this price?

Buying Corcept Therapeutics Incorporated (CORT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.